HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling
Autor: | Keke Wang, Yaxin Chen, Yang Zhou, Rui Wang, Tao Li, Rong Hu, Mengran Cao, Mengdi Yang, Yunjiang Zhou |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
PDAC pancreatic ductal adenocarcinoma Clinical Biochemistry HEATR1 Gemcitabine resistance Nrf2 nuclear factor erythroid 2-related factor 2 Deoxycytidine Biochemistry 0302 clinical medicine Cytotoxic T cell SQSTM1 sequestosome 1 lcsh:QH301-705.5 HO-1 heme oxygenase-1 chemistry.chemical_classification education.field_of_study Gene knockdown lcsh:R5-920 Kelch-Like ECH-Associated Protein 1 RNA-Binding Proteins mRNA messenger RNA Amino acid Keap1 Kelch-like ECH-associated protein 1 shRNA short hairpin RNA HEATR1 human HEAT repeat-containing protein 1 lcsh:Medicine (General) Research Paper NF-E2-Related Factor 2 qRT-PCR quantitative reverse transcription-PCR Biology Nrf2 Minor Histocompatibility Antigens 03 medical and health sciences Sequestosome 1 Cell Line Tumor Pancreatic cancer NQO1 NAD(P)H quinone oxidoreductase 1 medicine Humans education Cell Proliferation Organic Chemistry medicine.disease Gemcitabine KEAP1 Pancreatic Neoplasms 030104 developmental biology chemistry lcsh:Biology (General) Cancer research 030217 neurology & neurosurgery Nrf2 signaling |
Zdroj: | Redox Biology, Vol 29, Iss, Pp-(2020) Redox Biology |
ISSN: | 2213-2317 |
Popis: | The human HEAT repeat-containing protein 1 (HEATR1), consisting of 2144 amino acids, is a member of the UTP10 family and contains one HEAT repeat at its C-terminal. HEATR1 has been reported to regulate cytotoxic T lymphocytes and rRNA synthesis, while its functions in tumors are poorly understood. Here, we found that HEATR1 competed with Keap1 for binding to p62/sequestosome 1 (SQSTM1), resulted in up-regulation of Keap1, which then inhibited Nrf2 signaling in pancreatic cancer cells. HEATR1 knockdown enhanced proliferation and gemcitabine resistance of pancreatic cancer cells. Moreover, HEATR1 deficiency significantly improved xenografts growth and led to gemcitabine resistance in pancreatic cancer cell-derived xenografts through up-regulating Nrf2 signaling. By analyzing tumor tissue samples from pancreatic cancer patients, we found that low expression of HEATR1 was closely correlated with poor prognosis and clinicopathological features. Collectively, we suggest that HEATR1 deficiency promotes proliferation and gemcitabine resistance of pancreatic cancer through up-regulating Nrf2 signaling, indicating that HEATR1 may be a promising therapeutic target for pancreatic cancer. Highlights • HEATR1 inhibited Nrf2 signaling in pancreatic cancer cells. • HEATR1 inhibited Nrf2 signaling through competing with Keap1 for p62 binding in pancreatic cancer cells. • HEATR1 deficiency promoted pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling. |
Databáze: | OpenAIRE |
Externí odkaz: |